Cargando…
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890247/ https://www.ncbi.nlm.nih.gov/pubmed/36544352 http://dx.doi.org/10.1093/jac/dkac433 |
| _version_ | 1784880909990756352 |
|---|---|
| author | Graziani, Lucia Gori, Leonardo Manciulli, Tommaso Basile, Gregorio Campolmi, Irene Borchi, Beatrice di Dio, Marta Mattei, Marta Ciurleo, Greta Ciliberti, Maria Malentacchi, Francesca Coppi, Marco Morettini, Alessandro Parronchi, Paola Rossolini, Gian Maria Bartoloni, Alessandro Tomassetti, Sara Spinicci, Michele |
| author_facet | Graziani, Lucia Gori, Leonardo Manciulli, Tommaso Basile, Gregorio Campolmi, Irene Borchi, Beatrice di Dio, Marta Mattei, Marta Ciurleo, Greta Ciliberti, Maria Malentacchi, Francesca Coppi, Marco Morettini, Alessandro Parronchi, Paola Rossolini, Gian Maria Bartoloni, Alessandro Tomassetti, Sara Spinicci, Michele |
| author_sort | Graziani, Lucia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9890247 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98902472023-02-02 Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 Graziani, Lucia Gori, Leonardo Manciulli, Tommaso Basile, Gregorio Campolmi, Irene Borchi, Beatrice di Dio, Marta Mattei, Marta Ciurleo, Greta Ciliberti, Maria Malentacchi, Francesca Coppi, Marco Morettini, Alessandro Parronchi, Paola Rossolini, Gian Maria Bartoloni, Alessandro Tomassetti, Sara Spinicci, Michele J Antimicrob Chemother Research Letter Oxford University Press 2022-12-21 /pmc/articles/PMC9890247/ /pubmed/36544352 http://dx.doi.org/10.1093/jac/dkac433 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Research Letter Graziani, Lucia Gori, Leonardo Manciulli, Tommaso Basile, Gregorio Campolmi, Irene Borchi, Beatrice di Dio, Marta Mattei, Marta Ciurleo, Greta Ciliberti, Maria Malentacchi, Francesca Coppi, Marco Morettini, Alessandro Parronchi, Paola Rossolini, Gian Maria Bartoloni, Alessandro Tomassetti, Sara Spinicci, Michele Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title | Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title_full | Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title_fullStr | Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title_full_unstemmed | Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title_short | Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
| title_sort | successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing covid-19 |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890247/ https://www.ncbi.nlm.nih.gov/pubmed/36544352 http://dx.doi.org/10.1093/jac/dkac433 |
| work_keys_str_mv | AT grazianilucia successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT gorileonardo successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT manciullitommaso successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT basilegregorio successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT campolmiirene successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT borchibeatrice successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT didiomarta successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT matteimarta successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT ciurleogreta successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT cilibertimaria successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT malentacchifrancesca successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT coppimarco successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT morettinialessandro successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT parronchipaola successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT rossolinigianmaria successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT bartolonialessandro successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT tomassettisara successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 AT spiniccimichele successfuluseofnirmatrelvirritonavirinimmunocompromisedpatientswithpersistentandorrelapsingcovid19 |